These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16896659)

  • 21. Brain natriuretic peptide and cardiac autonomic function in type 2 diabetic patients.
    Yufu K; Takahashi N; Nakagawa M; Hara M; Saikawa T; Yoshimatsu H
    Diabetes Res Clin Pract; 2006 Apr; 72(1):12-9. PubMed ID: 16298451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
    de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
    J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced serum homocysteine levels in type 2 diabetes.
    Mazza A; Bossone E; Mazza F; Distante A
    Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):118-24. PubMed ID: 15871860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria.
    Stehouwer CD; Gall MA; Hougaard P; Jakobs C; Parving HH
    Kidney Int; 1999 Jan; 55(1):308-14. PubMed ID: 9893141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus.
    Nagamachi S; Fujita S; Nishii R; Futami S; Tamura S; Mizuta M; Nakazato M; Kurose T; Wakamatsu H
    J Nucl Cardiol; 2006; 13(1):34-42. PubMed ID: 16464715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy parameter predicts cardiac and cerebrovascular events in type 2 diabetic patients without structural heart disease.
    Yufu K; Takahashi N; Okada N; Shinohara T; Nakagawa M; Hara M; Yoshimatsu H; Saikawa T
    Circ J; 2012; 76(2):399-404. PubMed ID: 22130318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The impact of plasma homocysteine level on development of retinopathy in type 2 diabetes mellitus].
    Yang G; Lu J; Pan C
    Zhonghua Nei Ke Za Zhi; 2002 Jan; 41(1):34-8. PubMed ID: 11940295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [123I-MIBG myocardial scintigraphy in diabetic patients: association with autonomic neuropathy].
    Nagamachi S; Hoshi H; Ohnishi T; Jinnouchi S; Futami S; Watanabe K; Nakatsuru K; Toshimori T; Matsukura S
    Kaku Igaku; 1994 Sep; 31(9):1059-69. PubMed ID: 7967189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of 123I-MIBG after acute myocardial infarction and reperfusion therapy.
    Bengel FM; Barthel P; Matsunari I; Schmidt G; Schwaiger M
    J Nucl Med; 1999 Jun; 40(6):904-10. PubMed ID: 10452304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High plasma homocysteine concentrations are associated with plasma concentrations of thrombomodulin in patients with type 2 diabetes and link diabetic nephropathy to macroangiopathy.
    Okumura K; Aso Y
    Metabolism; 2003 Nov; 52(11):1517-22. PubMed ID: 14624417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperhomocysteinemia and impaired vasomotor function in type 2 diabetes mellitus.
    Tan KC; O K; Chow WS; Ai VH; Siow YL; Lam KS
    Eur J Clin Invest; 2002 May; 32(5):328-34. PubMed ID: 12027872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus.
    Abdella NA; Mojiminiyi OA; Akanji AO; Moussa MA
    Acta Diabetol; 2002 Dec; 39(4):183-90. PubMed ID: 12486492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homocysteine levels are not associated with cardiovascular autonomic function in elderly Caucasian subjects without or with type 2 diabetes mellitus: the Hoorn Study.
    Spoelstra-De Man AM; Smulders YM; Dekker JM; Heine RJ; Bouter LM; Nijpels G; Stehouwer CD
    J Intern Med; 2005 Dec; 258(6):536-43. PubMed ID: 16313477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.
    Langer A; Freeman MR; Josse RG; Armstrong PW
    J Am Coll Cardiol; 1995 Mar; 25(3):610-8. PubMed ID: 7860904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors.
    Dinleyici EC; Kirel B; Alatas O; Muslumanoglu H; Kilic Z; Dogruel N
    J Trop Pediatr; 2006 Aug; 52(4):260-6. PubMed ID: 16401615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fractions of total plasma homocysteine in patients with ischemic stroke before the age of 55 years.
    Sobol AB; Bald E; Loba J
    Angiology; 2005; 56(2):201-9. PubMed ID: 15793609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel method for the assessment of autonomic neuropathy in type 2 diabetic patients: a comparative evaluation of 123I-MIBG myocardial scintigraphy and power spectral analysis of heart rate variability.
    Murata K; Sumida Y; Murashima S; Matsumura K; Takeda H; Nakagawa T; Shima T
    Diabet Med; 1996 Mar; 13(3):266-72. PubMed ID: 8689849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP].
    Yahara Y; Nomura Y; Okamoto S; Saitou K; Okamoto R; Makino K; Aoki S; Takeda K
    Kaku Igaku; 2000 May; 37(3):217-25. PubMed ID: 10860352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitus.
    Genest J; Frohlich J; Steiner G
    Am J Cardiol; 2004 Apr; 93(7):848-53. PubMed ID: 15050487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
    Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.